Authors

Matthew Royle, Ph.D.

Partner

Read More

Adrian Toutoungi

Partner

Read More

Paul England, DPhil

Senior professional support lawyer

Read More
Authors

Matthew Royle, Ph.D.

Partner

Read More

Adrian Toutoungi

Partner

Read More

Paul England, DPhil

Senior professional support lawyer

Read More

27 July 2020 | 39:23

Dissecting the Regeneron v Kymab mouse case – what it says and its impact on patents

The Supreme Court's Regeneron Pharmaceuticals Inc v Kymab Ltd decision to revoke two patents for transgenic mouse technology has caused concern to biotech patent owners, especially since the Supreme Court expressed a need to rebalance patent law.

Has this case shifted the boundaries of patent protection, or merely clarified the status quo? What is its context, and broader impact on patents both within and outside the life sciences technology area?

Our experts explain the case and answer these questions in this webinar.

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

pills
Patents & innovation

IP: Licensing and insolvency

23 July 2020
QUICK READ

by multiple authors

Click here to find out more
woman-with-scientific-model
Life sciences & healthcare

Everything biologic and biosimilar in-house counsel need to know about COVID-19

29 April 2020

by multiple authors

Click here to find out more
Life sciences & healthcare

The Bolar and related exemptions in Europe

What activity do they cover?

5 March 2020

by multiple authors

Click here to find out more

Related events

There are no upcoming events